Saxagliptin 5mg
Sponsors
AstraZeneca, Sabyasachi Sen, University of Pisa, Eric Grouzmann, Ain Shams University
Conditions
Cardiovascular DiseasesDiabetes Mellitus, Type 2Drug InteractionErectile Dysfunction With Diabetes MellitusPhysical ActivitySecretion; CatecholamineSympathetic Nervous SystemType 2 Diabetes Mellitus
Early Phase 1
Phase 2
Phase 3
Phase 4
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
TerminatedNCT03660683
Start: 2018-10-22End: 2021-12-10Updated: 2023-06-05
Tubular Markers in Response to Saxagliptin Therapy
CompletedNCT04521049
Start: 2019-03-01End: 2020-04-01Updated: 2020-08-20